Preclinical Evaluation of Botulinum Toxin Type E (TrenibotulinumtoxinE) Using the Mouse Digit Abduction Score (DAS) Assay
TrenibotulinumtoxinE (trenibotE), a botulinum neurotoxin serotype E (BoNT/E), is being developed for clinical use, and can fill a unique treatment gap for patients who are seeking neurotoxin treatment with a rapid onset and short duration of effect. This preclinical study characterized the pharmacol...
Saved in:
| Main Authors: | Gregory S. Nicholson, David Canty, Annemarie Southern, Kevin Whelan, Amy D. Brideau-Andersen, Ron S. Broide |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Series: | Toxins |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2072-6651/17/5/230 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Combined treatment with antitoxin and 3,4-diaminopyridine improves survival outcomes after lethal botulinum neurotoxin challenge
by: Sean W. O’Brien, et al.
Published: (2025-07-01) -
The Effect of Micro-Focused Ultrasound Treatment on Intradermal Botulinum Toxin Type A Injection
by: Sarawin Harnchoowong, et al.
Published: (2025-03-01) -
Applications, impacts and consequences of botulinum toxin usage in medicine
by: Weronika Kiełt, et al.
Published: (2024-10-01) -
A nerve clamp electrode design for indirect stimulation of skeletal muscle
by: Corey J. Hilmas, et al.
Published: (2010-10-01) -
The Use of Botulinum Toxin A in the Management of Trigeminal Neuralgia: a Systematic Literature Review
by: Anton Rubis, et al.
Published: (2020-06-01)